ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Assessment of the Ability to Distinguish Odors in Glaucoma Patients

This study has been completed.

Sponsored by: University Hospital, Basel, Switzerland
Information provided by: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT00304824
  Purpose

Glaucoma is one of the leading causes of blindness worldwide. The key feature of glaucoma is damage to the optic nerve head with loss of retinal ganglion cells and local tissue remodeling. Neuronal cell death in glaucoma occurs by apoptotic mechanisms1. Apoptosis of neurons also plays a major role in neurodegenerative diseases, such as Alzheimer's or Parkinson's disease. An association between glaucoma and these disorders has been described 2-4. Furthermore, it has been reported that the olfactory function is disturbed in these neurodegenerative diseases5-6. We hypothesize that similar olfactory alterations may occur in glaucoma which is in fact a local neurodegenerative disease.


Condition
Glaucoma

Genetics Home Reference related topics:   early-onset glaucoma   

MedlinePlus related topics:   Degenerative Nerve Diseases    Glaucoma   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Natural History, Cross-Sectional, Case Control, Prospective Study
Official Title:   Olfactory Function in Glaucoma Patients

Further study details as provided by University Hospital, Basel, Switzerland:

Enrollment:   30
Study Start Date:   October 2004
Study Completion Date:   November 2005

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   17 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

Chronic open-angle glaucoma with typical glaucomatous disc and visual field damage.

Exclusion Criteria:

  • Occludable iridocorneal angles
  • History of current, chronic or recurrent inflammatory eye disease
  • History of retinal or neuroophthalmologic disease that could result in visual field defects
  • Need for any concomitant medications that may interfere with the evaluation of olfactory function
  • Patients with a significant history and/or active alcohol or drug abuse (significant is defined as that which in the opinion of the investigator may either put the patient at risk because of participation in the study or may influence the results of the study or the patient's ability to participate in the study), smokers
  • History of olfactory disturbance related to identifiable local factors and any local condition that could lead to hyposmia/anosmia or interfere with the olfactory function, such as polyps, chronic sinus infection, sub(acute) viral or bacterial infection, history of sinus surgery
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00304824

Sponsors and Collaborators
University Hospital, Basel, Switzerland

Investigators
Study Director:     Selim Orgul     University Eye Hospital Basel, Switzerland    
  More Information

University Basel, Switzerland  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   009-Guk-2004-002
First Received:   March 17, 2006
Last Updated:   September 4, 2007
ClinicalTrials.gov Identifier:   NCT00304824
Health Authority:   Switzerland: Swissmedic

Keywords provided by University Hospital, Basel, Switzerland:
Glaucoma  
Olfactory functions  
Sniffin Sticks Test  

Study placed in the following topic categories:
Glaucoma
Eye Diseases
Hypertension
Ocular Hypertension

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers